Day One Biopharmaceuticals (DAWN) Current Leases: 2022-2025
Historic Current Leases for Day One Biopharmaceuticals (DAWN) over the last 4 years, with Sep 2025 value amounting to $161,000.
- Day One Biopharmaceuticals' Current Leases rose 109.09% to $161,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $161,000, marking a year-over-year increase of 109.09%. This contributed to the annual value of $10,000 for FY2024, which is 97.55% down from last year.
- Day One Biopharmaceuticals' Current Leases amounted to $161,000 in Q3 2025, which was up 5.23% from $153,000 recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' Current Leases registered a high of $462,000 during Q3 2022, and its lowest value of $10,000 during Q4 2024.
- Moreover, its 3-year median value for Current Leases was $190,000 (2024), whereas its average is $240,273.
- As far as peak fluctuations go, Day One Biopharmaceuticals' Current Leases soared by 143.86% in 2023, and later slumped by 97.55% in 2024.
- Over the past 4 years, Day One Biopharmaceuticals' Current Leases (Quarterly) stood at $405,000 in 2022, then increased by 0.74% to $408,000 in 2023, then crashed by 97.55% to $10,000 in 2024, then skyrocketed by 109.09% to $161,000 in 2025.
- Its Current Leases stands at $161,000 for Q3 2025, versus $153,000 for Q2 2025 and $62,000 for Q1 2025.